FDA classifies Inventia Healthcare chlorthalidone recall as Class II

FDA classifies Inventia Healthcare chlorthalidone recall as Class II

健康
登录后即可置顶此事件

The U. S.

Food and Drug Administration classified the recall of Inventia Healthcare Limited’s 25-mg chlorthalidone tablets as a Class II action on September 29, after quality tests showed the tablets failed to dissolve properly. Inventia Healthcare had voluntarily recalled 13,567 bottles of the medication on September 17, following FDA testing that indicated the tablets did not meet dissolution standards.

参与者

U.S. Food and Drug Administration Inventia Healthcare Limited Jennifer Young, PharmD Institute for Safe Medication Practices

地点

United States

文章

2026年九月29日
2 篇总计
Widely used blood pressure medication recalled nationwide
Widely used blood pressure medication recalled nationwide

Fox Business • 09月29日 20:05

The FDA classified the recall of Inventia Healthcare's 25-mg chlorthalidone tablets as a Class II action after quality tests showed the tablets did not dissolve properly.

可信度 78% 操纵 8% 中立
Popular blood pressure drug recalled over dissolution issues
Popular blood pressure drug recalled over dissolution issues

New York Post • 09月29日 13:49

Inventia Healthcare Limited is voluntarily recalling 13,567 bottles of 25 mg chlorthalidone tablets after FDA testing showed they did not meet dissolution standards, marking the company's second Class II recall this year.

可信度 78% 操纵 8% 中立
2026年九月27日
3 篇总计
FDA Announces New Nationwide Blood Pressure Medication Recall
FDA Announces New Nationwide Blood Pressure Medication Recall

Yahoo • 09月27日 17:06

The FDA has designated a September recall of certain chlorthalidone tablets by Inventia Healthcare as a Class II recall, citing failed dissolution specifications.

可信度 78% 操纵 8% 中立
FDA Announces New Nationwide Blood Pressure Medication Recall
FDA Announces New Nationwide Blood Pressure Medication Recall

AOL.com • 09月27日 17:06

The FDA has designated a September recall of Inventia Healthcare's chlorthalidone tablets as a Class II recall, citing failed dissolution specifications.

可信度 72% 操纵 7% 中立
FDA Announces New Nationwide Blood Pressure Medication Recall
FDA Announces New Nationwide Blood Pressure Medication Recall

Yahoo News Singapore • 09月27日 17:06

The FDA has designated a September recall of certain chlorthalidone tablets by Inventia Healthcare as a Class II recall, citing failed dissolution specifications.

可信度 78% 操纵 5% 中立
2026年九月24日
1 篇总计
FDA Announces Recall on Blood Pressure Medication-More Than 13,000 Bottles Affected Nationwide
FDA Announces Recall on Blood Pressure Medication-More Than 13,000 Bottles Affected Nationwide

AOL.com • 09月24日 16:34

The U.S. Food and Drug Administration has recalled more than 13,000 bottles of the blood-pressure drug chlorthalidone after dissolution tests failed, urging patients to consult their providers.

可信度 78% 操纵 8% 中立

相关事件